Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity

  • Mengle Shao
  • , Chelsea Hepler
  • , Qianbin Zhang
  • , Bo Shan
  • , Lavanya Vishvanath
  • , Gervaise H. Henry
  • , Shangang Zhao
  • , Yu A. An
  • , Yibo Wu
  • , Douglas W. Strand
  • , Rana K. Gupta

Producción científica: Articlerevisión exhaustiva

74 Citas (Scopus)

Resumen

How adipocyte precursor cells are regulated to control depot-specific adipose tissue expansion in obesity remains unclear. Here, Shao et al. identify a HIFα-dependent regulatory mechanism controlling adipocyte progenitor activity in mice and demonstrate the ability of the anti-cancer drug Imatinib to promote metabolically beneficial adipogenesis in obesity.

Idioma originalEnglish (US)
Páginas (desde-hasta)685-701.e7
PublicaciónCell Stem Cell
Volumen28
N.º4
DOI
EstadoPublished - abr 1 2021

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Huella

Profundice en los temas de investigación de 'Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity'. En conjunto forman una huella única.

Citar esto